Gilead’s Liver-Drug Setback Jeopardizes $35 Billion Dream – Yahoo Finance

Share this Story

Drugmakersare in a race to develop medicinesthat could potentially treatmillions of patients and generate as much $35billionin theoretical sales.Few have been as aggressive in that pursuit as Gilead Sciences Inc., which has multiple drugsfor the condit…

Author: Unknown